The FDA issued a statement indicating that marijuana had no currently accepted medical uses. Stories in the New York Times, the Washington Post, and the Associated Press reported on this statement and responses to it within and outside the medical community. Prof. Lyle Craker is quoted discussing his lawsuit against the DEA for refusing to issue him a license for a marijuana production facility. NIDA’s marijuana was criticized for poor quality, but not for the more comprehensive lack of an “adequate and uninterrupted” supply that is the basis of Prof. Craker’s lawsuit. FDA’s statement wasn’t that marijuana had no medical uses. Rather, what the statement actually means is that due to a lack of research data from large Phase III studies, which won’t take place until NIDA’s marijuana monopoly is broken, FDA will consider marijuana to have no currently accepted medical uses. This statment points yet again to the need for large-scale, privately-funded Phase III studies with smoked and vaporized marijuana, which DEA is blocking by refusing to issue Prof. Craker his license.